STORAGE MANAGEMENT OF CLINICAL RESEARCH SUPPLIES OF A PHASE IIB/III, NATIONAL, MULTI-CENTRE, DOUBLE-BLIND AND RANDOMIZED STUDY

被引:0
|
作者
Harada, Lila M. [1 ]
Rodrigues, Enio Fernandes [1 ]
Ferreira, William de Paula [1 ]
da Silva, Adriano Manicoba [1 ]
Kawamoto Junior, Luiz Teruo [1 ]
机构
[1] Fed Inst Educ Sci & Technol Sao Paulo IFSP, Suzano, SP, Brazil
关键词
Clinical Trial; Supply; Storage; Good practices;
D O I
10.14488/BJOPM.2016.v13.n4.a3
中图分类号
C93 [管理学]; O22 [运筹学];
学科分类号
070105 ; 12 ; 1201 ; 1202 ; 120202 ;
摘要
New drugs suffer a long and slow proceeding to reach the market. On the one hand there are difficulties from the regulatory agency that delays the onset of clinical trial studies, on the other hand there is a slow patient recruitment during the course of the trial that prevents its completion. An efficient management of clinical trial supplies throughout the supply chain is essential. Thus, the objective of this study was to characterize the clinical supplies storage management in a national, multi-centre, double-blind and randomized study to evaluate the efficiency and safety of a combination of drugs to treat acute pain. The study was primarily focused on storage conditions of clinical supplies, detailing their distribution to the research sites. According to the data observed in this study, the clinical supplies storage management was not determinant for the slow patient recruitment process that reflected the delay to the end of the study. And although the centers were located in different states, there were no delays, loss or damage during storage and distribution that could compromise the proper stock and storage management of clinical trial supplies.
引用
收藏
页码:430 / 441
页数:12
相关论文
共 50 条
  • [1] Quality management of a large randomized double-blind multi-centre trial: The ACTION experience
    Kirwan, Bridget-Anne
    Lubsen, Jacobus
    de Brouwer, Sophie
    van Dalen, Frederik J.
    Pocock, Stuart J.
    Clayton, Tim
    Danchin, Nicolas
    Poole-Wilson, Philip A.
    CONTEMPORARY CLINICAL TRIALS, 2008, 29 (02) : 259 - 269
  • [2] Tavipec® in acute rhinosinusitis: a multi-centre, double-blind, randomized, placebo-controlled, clinical trial
    Dejaco, Daniel
    Bocian-Sobkowska, Joanna
    Szymanski, Witold
    Zacke, Gabriele
    Hoeckner, Verena
    Riechelmann, Herbert
    RHINOLOGY, 2019, 57 (05) : 367 - 374
  • [3] DOUBLE-BLIND CONTROLLED MULTI-CENTRE STUDY COMPARING MIANSERIN AND IMIPRAMINE
    PULL, CB
    PICHOT, P
    PULL, MC
    DREYFUS, JF
    CURRENT MEDICAL RESEARCH AND OPINION, 1980, 6 : 81 - 86
  • [4] Double-blind evaluation and benchmarking of survival models in a multi-centre study
    Taktak, A.
    Antolini, L.
    Aung, M.
    Boracchi, P.
    Campbell, I.
    Damato, B.
    Ifeachor, E.
    Lama, N.
    Lisboa, P.
    Setzkorn, C.
    Stalbovskaya, V.
    Biganzoli, E.
    COMPUTERS IN BIOLOGY AND MEDICINE, 2007, 37 (08) : 1108 - 1120
  • [5] Citicoline in intracerebral haemorrhage:: A double-blind, randomized, placebo-controlled, multi-centre pilot study
    Secades, Julio J.
    Alvarez-Sabin, Jose
    Rubio, Francisco
    Lozano, Rafael
    Davalos, Antoni
    Castillo, Jose
    CEREBROVASCULAR DISEASES, 2006, 21 (5-6) : 380 - 385
  • [6] Decreasing risk of psychosis by sulforaphane study protocol for a randomized, double-blind, placebo-controlled, clinical multi-centre trial
    Li, Zhixing
    Zhang, Tianhong
    Xu, Lihua
    Wei, Yanyan
    Tang, Yingying
    Hu, Qiang
    Liu, Xiaohua
    Li, Xiaolong
    Davis, John
    Smith, Robert
    Jin, Hua
    Wang, Jijun
    EARLY INTERVENTION IN PSYCHIATRY, 2021, 15 (03) : 585 - 594
  • [7] Clinical tolerability of perioperative tenoxicam in 1001 patients - a prospective, controlled, double-blind, multi-centre study
    Merry, AF
    Webster, CS
    Holland, RL
    Middleton, NG
    Schug, SA
    James, M
    McGrath, KA
    PAIN, 2004, 111 (03) : 313 - 322
  • [8] Intramuscular midazolam, olanzapine, or haloperidol for the management of acute agitation: A multi-centre, double-blind, randomised clinical trial
    Chan, Esther W.
    Lao, Kim S. J.
    Lam, Lam
    Tsui, Sik-Hon
    Lui, Chun-Tat
    Wong, Chi-Pang
    Graham, Colin A.
    Cheng, Chi-Hung
    Chung, Tong-Shun
    Lam, Hiu-Fung
    Ting, Soo-Moi
    Knott, Jonathan C.
    Taylor, David M.
    Kong, David C. M.
    Leung, Ling-Pong
    Wong, Ian C. K.
    ECLINICALMEDICINE, 2021, 32
  • [9] Botulinum toxin as a preventive treatment for migraine:: a randomized double-blind placebo-controlled multi-centre study
    Petri, S
    Tölle, T
    Pfaffenrath, V
    Stefenelli, U
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 238 : S89 - S89
  • [10] ZUCLOPENTHIXOL AND MELPERON IN THE TREATMENT OF ELDERLY PATIENTS - A DOUBLE-BLIND, CONTROLLED, MULTI-CENTRE STUDY
    NYGAARD, H
    BAKKE, K
    BRUDVIK, E
    LIEN, GK
    MOE, TJ
    ELGEN, K
    PHARMATHERAPEUTICA, 1987, 5 (03) : 152 - 158